Denmark· DK-28104623709
Brevibloc
A esmolol product containing esmololhydrochlorid, registered in Denmark by Baxter A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Esmolol is registered in 16 of 19 countries.
Countries holding a registration under ATC C07AB09 (esmolol), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Esmolol · ATC C07AB09
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ESMOLOLHYDROCHLORID
- Manufacturer
- Baxter A/S
- Country
- Denmark (DK)
- ATC code
- C07AB09
- ATC class
- Esmolol
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104623709
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for esmolol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Esmolol · interactions on record
196 records
- 11 severe
- 139 moderate
- 8 minor
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
38 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C07AB09
Esmolol, as other registers publish it.
- United StatesBreviblocBaxter Healthcare Company
- GermanyBreviblocBaxter Deutschland Gmbh
- United StatesBreviblocHenry Schein, Inc
- United StatesBreviblocBaxter Healthcare Company
- United StatesBreviblocBaxter Healthcare Company
- DenmarkBrevibloc2care4 ApS
- DenmarkBreviblocBaxter A/S
- DenmarkBreviblocAbacus Medicine A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/38e6b15c-6a7b-4755-a950-4fa72024fedb GET /v1/drugs/38e6b15c-6a7b-4755-a950-4fa72024fedb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "infusionsvæske, opløsning",
"source": "dkma",
"strength": "10 mg/ml",
"auth_role": "RMS",
"dk_drugid": "28104623709",
"substance": "ESMOLOLHYDROCHLORID",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "40408"
}See everything about esmolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.